DIGESTAID continues to be at the forefront of healthcare innovation, pushing the boundaries of gastrointestinal diagnostics. Our CEO recently delivered a lecture at the 2023 ACG Congress. He presented our latest research, “Deep Learning and Device-Assisted Enteroscopy: Multi-Device and Multi-Brand Detection of Pan-Endoscopic Pleomorphic Lesions.” This work introduces the world’s first panendoscopic deep learning model for detecting pleomorphic lesions, representing a significant leap in device-assisted enteroscopy.